Autopsy report · NCT06708936
KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study
Cause of deathFunding or business
“Due to a strategic adjustment, the company has decided to terminate the project.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Early Phase 1
- Sponsor
- Kousai Bio Co., Ltd.
- Sponsor type
- University, hospital or other
- Conditions
- Clear Cell Renal Cell Carcinoma (ccRCC)
- Interventions
- KSD-201
- Participants
- 0
- Sites
- 1
- Countries
- China
Trials that died the same way
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors(MEETCD8-001)
“Due to adjustments in the sponsor's development strategy, it has been decided to terminate the study.” - Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses
“Study was terminated due to a business decision to cancel the entire project.” - A Study to Compare the Efficacy and Safety of JHL1101 Versus Rituximab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL)
“The development was stopped due to company's strategy consideration” - A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT
“Terminated due to budgetary considerations and length of development.” - Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse
“Study prematurely terminated following the decision by industrial partner to withdraw from the project (product supply issue).”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.